ALERT: Due to the inclement weather across much of the country, Medtronic deliveries are currently experiencing delays and there will be longer than normal hold times on the phone. Visit www.Diabetes.shop if you need to place an order, get a sensor or belt clip replacement, or check the status of your supply order. X
Country selector icon United States
Important Product Safety InformationAlert: Product and Recall Notices
You are a #MedtronicChampion! Learn more »

X

Take the next step


Medtronic Products


Get started

En Español

INSULIN PUMP THERAPY.
AN ADVANCED OPTION FOR DIABETES MANAGEMENT.

Learn more about how insulin pump therapy works, the benefits of pump therapy, and who it is suitable for.


Get Started     Watch Video

What is insulin pump therapy?

An insulin pump is a small device that can help you manage your diabetes. It delivers continuous and customized doses of rapid-acting insulin 24 hours a day to match your body’s needs. The pump provides insulin to your body in two ways:


Background (Basal) insulin graph
BACKGROUND (BASAL) INSULIN
Small amounts of insulin that are released continuously throughout the day.

Mealtime (Bolus) insulin graph
MEALTIME (BOLUS) INSULIN
Additional insulin can be delivered on demand to match food intake or to correct high blood sugar.

How does an insulin pump work?

A pump delivers insulin to the body through a thin, flexible tube called an infusion set.


How does an insulin pump work?

What components are used as part of an insulin pump system?

Several pieces work together to deliver continuous doses of insulin.

Roll over the components below for more information.

Infusion Set Insertion Device
Reservoir
MiniMed 770G system components on the body

What are the Benefits of
Insulin Pump Therapy?

People can experience many positive changes in their life when switching to pump therapy.

Who can wear an
insulin pump?

Ask your healthcare professional about insulin pump therapy if you:

  • Take 3 or more insulin injections per day
  • Take other medications in addition to insulin to manage your diabetes
  • Would like better management of your diabetes

Where can you wear an insulin pump?

There are many ways a pump can be worn. It can be comfortably worn during work, exercise, formal occasions and everyday life. Hover over the images below to see how others wear their pump.


DISCREET

Wear it discreetWEAR IT DISCREET

PROUD

Wear it proudWEAR IT PROUD

ACTIVE∆

Wear it activeWEAR IT BOLD

Does Insurance Cover an Insulin Pump?

When it comes to your diabetes management, cost should not prevent you from accessing advanced diabetes technology. Our team will work with you to help ensure that you can experience the benefits of insulin pump therapy.

PRIVATE INSURANCE‡
Most private insurance companies cover insulin pumps under the durable medical equipment portion of your policy. Depending on your insurance coverage, you might have to pay a deductible and/or percent of the cost (co-insurance). If your deductible and out-of-pocket maximum has been met, the insulin pump might be covered at 100% by your insurance.

GOVERNMENT INSURANCE‡
Government insurances such as Medicare and Medicaid may cover insulin pumps depending on the state and other requirements. A patient's out-of-pocket cost under government insurance varies depending on the policy.

INSURANCE PROCESSING
When you start the process of getting an insulin pump, you do not have to worry about the paperwork. Medtronic will help you every step of the way by verifying your insurance, providing an estimated out-of-pocket cost, collecting the documents from you and your physician, and submitting all the required documents to your insurance company.

PAYMENT OPTIONS
If you do not have insurance or need assistance with your out-of-pocket cost, Medtronic offers flexible payment options and a financial assistance program for qualifying customers.

Frequently asked questions

Medtronic insulin pumps are covered by most insurance plans. Your out-of-pocket cost varies depending on your insurance. We also offer financial assistance and monthly payment programs. If you would like to receive an insurance coverage check at no cost, call 888-350-5440 to speak to a Diabetes Therapy consultant.
Insulin pumps can be easily worn on or under your clothes very securely. The pump can also be detached for activities like swimming, showering and exercise so you can continue to live your life.*
Many insulin pumps are warranty-protected for a period of time. Medtronic insulin pumps have a standard warranty of 4 years to help ensure customers have peace of mind.
Many people find that an insulin pump is a convenient way to manage diabetes. For those that struggle using technology, product training and technical support can help ensure that wearing the insulin pump is not difficult.
An insulin pump is a small device worn externally that delivers customizable insulin doses. No surgery or hospital time required.
Insulin pumps are small devices so wearing a pump can be very discreet if desired. You can even completely hide your insulin pump by wearing it underneath your clothes.
There are many ways to sleep with an insulin pump. You can sleep with the pump clipped to your pajama waist band or undergarment. You can also sleep with a body pillow on the side and put your pump under the pillow. There are other creative ways to sleep with your pump and it all depends on what is most comfortable for you.
With the ability to disconnect, insulin pumps are designed to adapt to every moment of your life.
A MiniMed™ insulin pump comes with a 4-year warranty. If you were to experience a change in your pump’s functionality, you can contact our 24-Hour Technical Support to process a replacement pump.
Actor portrayal

TALK TO A DIABETES THERAPY CONSULTANT

Medtronic insulin pumps are covered by most insurance plans. To request a free insurance coverage check and learn more about your eligibility and potential out-of-pocket costs please complete the form below or call 1-888-350-5440 and one of our Diabetes Therapy consultants will be happy to assist you.

       

MINIMED™ 770G SYSTEM

MINIMED 770G INSULIN PUMP SYSTEM

The MiniMed™ 770G insulin pump system automatically adjusts background insulin every 5 minutes.† Using real-time glucose readings, the system is able to calculate a personalized amount of insulin to deliver based on your needs. The system connects directly with a smartphone, allowing you to easily view sugar levels and insulin delivery history.


Learn more

MINIMED™ 630G INSULIN PUMP WITH OPTIONAL CGM

MiniMed™ 630G Insulin pump with optional CGM

The MiniMed™ 630G insulin pump delivers precise doses of insulin to your body. When combined with our CGM, it takes action for you with the SmartGuard™ Suspend on low feature - providing protection that can help keep your glucose levels stable.∆ ,3


Learn more

* At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours. This is classified as IPX8 rating. See user guide for more details. The sensor and transmitter are water-resistant at 8 feet (2.4 meters) for up to 30 minutes. CGM readings may not be transmitted from the CGM to the pump while in water.
† Refers to SmartGuard™ Auto Mode. Some interaction required. Individual results may vary.
∆ WARNING: Do not use the Suspend on low feature to prevent or treat low glucose. Always confirm your sensor glucose reading using your BG meter, and follow the instructions of your healthcare professional to treat low glucose. Using Suspend on low alone to prevent or treat low glucose may result in prolonged hypoglycemia.
‡ Coverage guidelines for insulin pumps vary and are subject to the insurance companies published medical policies in effect at the time services are requested.
1. Heinemann L, Weyer C, Rauhaus M, Heinrichs S, Heise T. Variability of the metabolic effect of soluble insulin and the rapid-acting insulin anolog insulin aspart.Diabetes Care.1998;21:1910-1914.
2. Heise T, Nosek L, Ronn BB, et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes. 2004;53:1614-1620.
3. Bergenstal RM,Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311–320.

Individuals pictured and/or quoted here were compensated for spending the day with us and allowing us to photograph them and their family. Their thoughts and opinions are their own.

Important Safety Information: MiniMed™ 770G System With SmartGuard™ Technology
The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the AccuChek®Guide Test Strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safetyinformation#minimed-770g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library


Important Safety Information: MiniMed™ 670G System
The Medtronic MiniMed™ 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, seven years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 670G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian™ Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an Alternative Site (palm) or from a control solution test. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode.

WARNING: Medtronic performed an evaluation of the MiniMed™ 670G system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin dose of 8 units per day because the device requires a minimum of 8 units per day to operate safely.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 670G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-670g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library.

Important Safety Information: MiniMed™ 630G System
Indicated for the continuous delivery of insulin, at set and variable rates, for the management of diabetes mellitus. MiniMed™ 630G system is approved for ages 14 years or older with Guardian™ Sensor 3 and MiniMed™ 630G system is approved for ages 16 years or older with Enlite™ sensor. Both systems require a prescription. Insulin infusion pumps and associated components of insulin infusion systems are limited to sale by or on the order of a physician and should only be used under the direction of a healthcare professional familiar with the risks of insulin pump therapy. Pump therapy is not recommended for people who are unwilling or unable to perform a minimum of four blood glucose tests per day. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Insulin pumps use rapid-acting insulin. If your insulin delivery is interrupted for any reason, you must be prepared to replace the missed insulin immediately. Replace the infusion set every 48–72 hours, or more frequently per your healthcare professional’s instructions. Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected. The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a blood glucose meter. A confirmatory fingerstick using a CONTOUR®NEXT LINK 2.4 meter is required prior to making adjustments to diabetes therapy. Always check the pump display when using a CONTOUR®NEXT LINK 2.4 meter, to ensure the glucose result shown agrees with the glucose results shown on the meter. Do not calibrate your CGM device or calculate a bolus using a result taken from an Alternative Site (palm) or a result from a control solution test. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. The MiniMed™ 630G system is not intended to be used directly for preventing or treating hypoglycemia but to suspend insulin delivery when the user is unable to respond to the Suspend on low alarm and take measures to prevent or treat hypoglycemia themselves. Therapy to prevent or treat hypoglycemia should be administered according to the recommendations of the user’s healthcare provider.

WARNING: The SmartGuard™ Suspend on low feature will cause the pump to temporarily suspend insulin delivery for two hours when the sensor glucose reaches a set threshold. Under some conditions of use the pump can suspend again, resulting in very limited insulin delivery. Prolonged suspension can increase the risk of serious hyperglycemia, ketosis, and ketoacidosis. Before using the SmartGuard feature, it is important to read the SmartGuard™ feature information in the User Guide and discuss proper use of the feature with your healthcare provider.

See important safety information and the appropriate user guides for additional important details.

Ascensia Diabetes Care

Ascensia, the Ascensia Diabetes Care logo, and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care.